her3-dxd,patritumab,ruxolitinib
amgen,daiichi sankyo,novartis,incyte
['patritumab', 'mbc', 'her3-dxd', 'bcsm', 'rux,(-crux),(-trux)']
patritumab deruxtecan (her3-dxd): an adc comprising an anti-her3 mab &amp; topoisomerase i inhibitor showing clinical activity across a broad range of her3 membrane expression levels in ptns with heavily pretreated er+ and tn mbc #bcsm #asco23 
Breast Medical Oncologist @UNC_Lineberger Prior @JCO_ASCO editorial fellow. Views are my own.